trial · primary record
NSI-8226
Asthma
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 145 |
| Primary completion | 2026-10-26 |
| Primary endpoint | To assess the effect of multiple doses of solrikitug on blood eosinophil counts compared with placebo |
| Registry ID | NCT06496607 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:27.017Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06496607
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.